Sorin SpA news

   Watch this stock
Showing stories 1 - 10 of about 104   

Articles published

SRN 1.90 0.00 (0.00%)
price chart
SORIN SPA : Sorin Group Launches REPLY(TM) 200 Family of Pacemakers with ...
Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today CE mark approval and the European commercial launch of the REPLY ?
Related articles »  
Charterhouse Said to Make Buyout Approach for Sorin
Charterhouse Capital Partners LLP approached shareholders of Sorin SpA (SRN) about buying the Italian maker of cardiovascular devices in a deal that would value the company at about 960 million euros ($1.2 billion), said people with knowledge of the ...
Related articles »  
Sorin's (SORJF) CEO Andr Ballester on Q2 2014 Results - Earnings Call ...
Sorin's (SORJF) CEO Andr Ballester on Q2 2014 Results - Earnings Call Transcript. Jul. 31, 2014 12:44 AM ET | About: Sorin S.p.A. (SORJF) by: SA Transcripts. Executives. Andr Ballester - CEO. Demetrio Mauro - CFO. Analysts. Mathieu Chabert - Bryan ...
Related articles »  
Sorin Falls on Report of Fatal Flaw in Heart Valve
Sorin SpA (SRN) fell the most in almost five years in Milan trading after Forbes reported that potentially fatal blockages have developed in the company's Mitroflow heart valve when used in children.
Related articles »  
Sorin Group Announces Preliminary Results for 2013
MILAN--(BUSINESS WIRE)--At a meeting held today and chaired by Rosario Bifulco, the Sorin S.p.A. Board of Directors analyzed the results for the fourth quarter 2013 and the preliminary unaudited consolidated results for the year of 2013.
Related articles »  
Sorin Group Announces Results for the First Quarter of 2013
For the second quarter of 2013, Sorin Group expects revenues to grow 1% to 3% at comparable exchange rates compared to the same period of 2012.
Related articles »  
Sorin Group Announces the First Implant of Solo Smart in the United States
Sorin Group, (Reuters Code: SORN.MI) (SRN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today that the first US implant of Solo Smart was performed by David Heimansohn, M.D.
Related articles »  
Sorin Group Announces CE Mark Approval and First Implant of MEMO 3D ...
Sorin Group, (SRN.MI) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today CE mark certification for its new MEMO 3D ReChord mitral valve annuloplasty ring that is now ...
Related articles »  
Sorin Group Announces Results of Perceval (TM) CAVALIER Trial and ...
Sorin Group, (SRN.MI) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, today announced the results of the Perceval CAVALIER Trial and of the Pooled European Multicenter Experience at ...
Sorin Group Announces FDA Approval of Solo Smart � the Next Evolution in ...
Sorin Group, (SRN.MI) (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S.
Related articles »